𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD5 and other superantigens as ‘ticklers’ of the B-cell receptor

✍ Scribed by Richard Pospisil; Rose G. Mage

Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
316 KB
Volume
19
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of CD22 and other inhibitory co
The role of CD22 and other inhibitory co-receptors in B-cell activation
✍ Lars Nitschke 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 1012 KB

Inhibitory co-receptors downmodulate B-cell receptor (BCR) signalling by setting a signalling threshold that prevents overstimulation of B cells. Activation of these inhibitory co-receptors occurs by phosphorylation on their cytoplasmic inhibitory immunoreceptor tyrosine-based inhibition motifs (ITI

The therapeutic effect of rituximab on C
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma
✍ Rie Hyo; Naoto Tomita; Kengo Takeuchi; Tomohiro Aoshima; Atsuko Fujita; Hideyuki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract The prognosis of diffuse large B‐cell lymphoma (DLBCL) has improved markedly in recent years of rituximab era. The prognosis of __de novo__ CD5‐positive DLBCL is reported to be poor, but the effect of rituximab on this type of lymphoma remains unclear. To investigate the effect of ritux

Expression of the T1 (CD5, p67) surface
Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers
✍ Dr. Domenico Delia; Antonio Bonati; Roberto Giardini; Silvia Villa; Filippo De B 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 742 KB

The TI surface antigen (CD5,p67) expression on blood lymphocytes (PBL) and lymphoid cells from lymph node biopsies (LN) from 31 patients with B-cell chronic lymphocytic leukemia (B-CLL) and 79 with B non-Hodgkin lymphoma (B-NHL), was detected in 25 B-CLL (80 per cent) and in 11 B-NHL (13 per cent) b